May 18, 2020 / 11:40 AM / 18 days ago

Moderna's experimental COVID-19 vaccine shows promise in early-stage study

May 18 (Reuters) - Moderna Inc said on Monday its experimental vaccine for COVID-19 showed promise in early trials and it looks to advance the vaccine into late-stage trials in July.

The vaccine, mRNA-1273, was also found to be generally safe and well tolerated in the early-stage study, the drug developer said. (Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Shinjini Ganguli)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below